What is Bicara Therapeutics's earnings yield?

Bicara Therapeutics (BCAX) reported earnings yield of -12.2% in Q1 2026.

How has Bicara Therapeutics's earnings yield changed year-over-year?

Bicara Therapeutics's earnings yield increased by 6.1% year-over-year, from -13% to -12.2%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Bicara Therapeutics BCAX Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

AmgenAMGN

4.1%+0.6pp

ArriVent BioPharma, Inc.AVBP

-14.2%-3.3pp

ImmunomeIMNM

-9.1%-3.9pp

Arcus BiosciencesRCUS

-13.6%-5.7pp

Syndax PharmaceuticalsSNDX

-11.8%-4.5pp

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Calculated from Bicara Therapeutics’s reported figures.

net income/market cap=-12.2%

Based on trailing twelve months.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's earnings yield?: Bicara Therapeutics (BCAX) reported earnings yield of -12.2% in Q1 2026.
How has Bicara Therapeutics's earnings yield changed year-over-year?: Bicara Therapeutics's earnings yield increased by 6.1% year-over-year, from -13% to -12.2%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.